Abstract
Summary
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The global Octreotide market is projected to reach US$ 2 million by 2032 from an estimated US$ 3 million in 2026, at a CAGR of -2.8% during 2026 and 2032.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Octreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Octreotide.
The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and revenue ($ millions), considering 2025 as the base year, with history and forecast data for the period from 2021 to 2032. This report segments the global Octreotide market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Octreotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Segment by Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Segment by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Octreotide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Octreotide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
The global Octreotide market is projected to reach US$ 2 million by 2032 from an estimated US$ 3 million in 2026, at a CAGR of -2.8% during 2026 and 2032.
Global Octreotide key players include Novartis, SUN, Tiantaishan pharmaceutical, Sinopharm A-Think, Sihuan Pharmaceutical, etc. Global top five manufacturers hold a share over 90%.
Europe is the largest market, with a share over 65%, followed by India and China, both have a share over 30%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Octreotide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Octreotide.
The Octreotide market size, estimations, and forecasts are provided in terms of sales volume (Gram) and revenue ($ millions), considering 2025 as the base year, with history and forecast data for the period from 2021 to 2032. This report segments the global Octreotide market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Octreotide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
Market Segmentation
By Company
Novartis
Sun Pharmaceutical
Chengdu Tiantaishan pharmaceutical
Sinopharm A-Think Pharmaceuticals
Sihuan Pharmaceutical Holdings Group
Shanghai Soho-Yiming Pharmaceuticals
Yibin Pharmaceutical
Segment by Type
Octreotide Injection
Octreotide Powder
Octreotide Microspheres
Segment by Application
Treating Severe Diarrhea
Treating Acromegaly
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Octreotide in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Octreotide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Octreotide sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
Table of Contents
1 Study Coverage
1.1 Octreotide Product Introduction
1.2 Market by Type
1.2.1 Global Octreotide Market Size Growth Rate by Type (2021 VS 2025 VS 2032)
1.2.2 Octreotide Injection
1.2.3 Octreotide Powder
1.2.4 Octreotide Microspheres
1.3 Market by Application
1.3.1 Global Octreotide Market Size Growth Rate by Application (2021 VS 2025 VS 2032)
1.3.2 Treating Severe Diarrhea
1.3.3 Treating Acromegaly
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Octreotide Market Size Estimates and Forecasts
2.1.1 Global Octreotide Revenue 2021-2032
2.1.2 Global Octreotide Sales 2021-2032
2.2 Octreotide Market Size by Region: 2025 Versus 2032
2.3 Octreotide Sales by Region (2021-2032)
2.3.1 Global Octreotide Sales by Region: 2021-2026
2.3.2 Global Octreotide Sales Forecast by Region (2027-2032)
2.3.3 Global Octreotide Sales Market Share by Region (2021-2032)
2.4 Octreotide Market Estimates and Projections by Region (2027-2032)
2.4.1 Global Octreotide Revenue by Region: 2021-2026
2.4.2 Global Octreotide Revenue Forecast by Region (2027-2032)
2.4.3 Global Octreotide Revenue Market Share by Region (2021-2032)
3 Global Octreotide by Manufacturers
3.1 Global Top Octreotide Manufacturers by Sales
3.1.1 Global Octreotide Sales by Manufacturer (2021-2026)
3.1.2 Global Octreotide Sales Market Share by Manufacturer (2021-2026)
3.2 Global Top Octreotide Manufacturers by Revenue
3.2.1 Global Octreotide Revenue by Manufacturer (2021-2026)
3.2.2 Global Octreotide Revenue Share by Manufacturer (2021-2026)
3.3 Global Octreotide Price by Manufacturer (2021-2026)
3.4 Competitive Landscape
3.4.1 Key Octreotide Manufacturers Covered: Ranking by Revenue
3.4.2 Global Octreotide Market Concentration Ratio (CR5 and HHI) & (2021-2026)
3.4.3 Global Octreotide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Octreotide Manufacturing Base Distribution, Product Type
3.5.1 Octreotide Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Octreotide Product Type
3.5.3 Date of International Manufacturers Enter into Octreotide Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Novartis
4.1.1 Novartis Company Information
4.1.2 Novartis Description, Business Overview
4.1.3 Novartis Octreotide Products Offered
4.1.4 Novartis Octreotide Sales, Revenue and Gross Margin (2021-2026)
4.1.5 Novartis Octreotide Sales by Product in 2025
4.1.6 Novartis Octreotide Sales by Application in 2025
4.1.7 Novartis Octreotide Sales by Geographic Area in 2025
4.1.8 Novartis Recent Developments
4.2 Sun Pharmaceutical
4.2.1 Sun Pharmaceutical Company Information
4.2.2 Sun Pharmaceutical Description, Business Overview
4.2.3 Sun Pharmaceutical Octreotide Products Offered
4.2.4 Sun Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2021-2026)
4.2.5 Sun Pharmaceutical Octreotide Sales by Product in 2025
4.2.6 Sun Pharmaceutical Octreotide Sales by Application in 2025
4.2.7 Sun Pharmaceutical Octreotide Sales by Geographic Area in 2025
4.2.8 Sun Pharmaceutical Recent Developments
4.3 Chengdu Tiantaishan pharmaceutical
4.3.1 Chengdu Tiantaishan pharmaceutical Company Information
4.3.2 Chengdu Tiantaishan pharmaceutical Description, Business Overview
4.3.3 Chengdu Tiantaishan pharmaceutical Octreotide Products Offered
4.3.4 Chengdu Tiantaishan pharmaceutical Octreotide Sales, Revenue and Gross Margin (2021-2026)
4.3.5 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Product in 2025
4.3.6 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Application in 2025
4.3.7 Chengdu Tiantaishan pharmaceutical Octreotide Sales by Geographic Area in 2025
4.3.8 Chengdu Tiantaishan pharmaceutical Recent Developments
4.4 Sinopharm A-Think Pharmaceuticals
4.4.1 Sinopharm A-Think Pharmaceuticals Company Information
4.4.2 Sinopharm A-Think Pharmaceuticals Description, Business Overview
4.4.3 Sinopharm A-Think Pharmaceuticals Octreotide Products Offered
4.4.4 Sinopharm A-Think Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2021-2026)
4.4.5 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Product in 2025
4.4.6 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Application in 2025
4.4.7 Sinopharm A-Think Pharmaceuticals Octreotide Sales by Geographic Area in 2025
4.4.8 Sinopharm A-Think Pharmaceuticals Recent Developments
4.5 Sihuan Pharmaceutical Holdings Group
4.5.1 Sihuan Pharmaceutical Holdings Group Company Information
4.5.2 Sihuan Pharmaceutical Holdings Group Description, Business Overview
4.5.3 Sihuan Pharmaceutical Holdings Group Octreotide Products Offered
4.5.4 Sihuan Pharmaceutical Holdings Group Octreotide Sales, Revenue and Gross Margin (2021-2026)
4.5.5 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Product in 2025
4.5.6 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Application in 2025
4.5.7 Sihuan Pharmaceutical Holdings Group Octreotide Sales by Geographic Area in 2025
4.5.8 Sihuan Pharmaceutical Holdings Group Recent Developments
4.6 Shanghai Soho-Yiming Pharmaceuticals
4.6.1 Shanghai Soho-Yiming Pharmaceuticals Company Information
4.6.2 Shanghai Soho-Yiming Pharmaceuticals Description, Business Overview
4.6.3 Shanghai Soho-Yiming Pharmaceuticals Octreotide Products Offered
4.6.4 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales, Revenue and Gross Margin (2021-2026)
4.6.5 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Product in 2025
4.6.6 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Application in 2025
4.6.7 Shanghai Soho-Yiming Pharmaceuticals Octreotide Sales by Geographic Area in 2025
4.6.8 Shanghai Soho-Yiming Pharmaceuticals Recent Development
4.7 Yibin Pharmaceutical
4.7.1 Yibin Pharmaceutical Company Information
4.7.2 Yibin Pharmaceutical Description, Business Overview
4.7.3 Yibin Pharmaceutical Octreotide Products Offered
4.7.4 Yibin Pharmaceutical Octreotide Sales, Revenue and Gross Margin (2021-2026)
4.7.5 Yibin Pharmaceutical Octreotide Sales by Product in 2025
4.7.6 Yibin Pharmaceutical Octreotide Sales by Application in 2025
4.7.7 Yibin Pharmaceutical Octreotide Sales by Geographic Area in 2025
4.7.8 Yibin Pharmaceutical Recent Development
5 Breakdown Data by Type
5.1 Global Octreotide Sales by Type (2021-2032)
5.1.1 Global Octreotide Sales by Type (2021-2026)
5.1.2 Global Octreotide Sales Forecast by Type (2027-2032)
5.1.3 Global Octreotide Sales Market Share by Type (2021-2032)
5.2 Global Octreotide Revenue Forecast by Type (2021-2032)
5.2.1 Global Octreotide Revenue by Type (2021-2026)
5.2.2 Global Octreotide Revenue Forecast by Type (2027-2032)
5.2.3 Global Octreotide Revenue Market Share by Type (2021-2032)
5.3 Octreotide Average Selling Price (ASP) by Type (2021-2032)
6 Breakdown Data by Application
6.1 Global Octreotide Sales by Application (2021-2032)
6.1.1 Global Octreotide Sales by Application (2021-2026)
6.1.2 Global Octreotide Sales Forecast by Application (2027-2032)
6.1.3 Global Octreotide Sales Market Share by Application (2021-2032)
6.2 Global Octreotide Revenue Forecast by Application (2021-2032)
6.2.1 Global Octreotide Revenue by Application (2021-2026)
6.2.2 Global Octreotide Revenue Forecast by Application (2027-2032)
6.2.3 Global Octreotide Revenue Market Share by Application (2021-2032)
6.3 Octreotide Average Selling Price (ASP) by Application (2021-2032)
7 North America
7.1 North America Octreotide Market Size YoY Growth 2021-2032
7.2 North America Octreotide Market Facts & Figures by Country
7.2.1 North America Octreotide Sales by Country (2021-2032)
7.2.2 North America Octreotide Revenue by Country (2021-2032)
7.3 North America Octreotide Sales by Type (2021-2026)
7.4 North America Octreotide Sales by Application (2021-2026)
8 Asia-Pacific
8.1 Asia-Pacific Octreotide Market Size YoY Growth 2021-2032
8.2 Asia-Pacific Octreotide Market Facts & Figures by Region
8.2.1 Asia-Pacific Octreotide Sales by Region (2021-2032)
8.2.2 Asia-Pacific Octreotide Revenue by Region (2021-2032)
8.3 Asia-Pacific Octreotide Sales by Type (2021-2026)
8.4 Asia-Pacific Octreotide Sales by Application (2021-2026)
9 Europe
9.1 Europe Octreotide Market Size YoY Growth 2021-2032
9.2 Europe Octreotide Market Facts & Figures by Country
9.2.1 Europe Octreotide Sales by Country (2021-2032)
9.2.2 Europe Octreotide Revenue by Country (2021-2032)
9.3 Europe Octreotide Sales by Type (2021-2026)
9.4 Europe Octreotide Sales by Application (2021-2026)
10 Latin America
10.1 Latin America Octreotide Market Size YoY Growth 2021-2032
10.2 Latin America Octreotide Market Facts & Figures by Country
10.2.1 Latin America Octreotide Sales by Country (2021-2032)
10.2.2 Latin America Octreotide Revenue by Country (2021-2032)
10.3 Latin America Octreotide Sales by Type (2021-2026)
10.4 Latin America Octreotide Sales by Application (2021-2026)
11 Middle East and Africa
11.1 Middle East and Africa Octreotide Market Size YoY Growth 2021-2032
11.2 Middle East and Africa Octreotide Market Facts & Figures by Country
11.2.1 Middle East and Africa Octreotide Sales by Country (2021-2032)
11.2.2 Middle East and Africa Octreotide Revenue by Country (2021-2032)
11.3 Middle East and Africa Octreotide Sales by Type (2021-2026)
11.4 Middle East and Africa Octreotide Sales by Application (2021-2026)
12 Supply Chain and Sales Channel Analysis
12.1 Octreotide Supply Chain Analysis
12.2 Octreotide Key Raw Materials and Upstream Suppliers
12.3 Octreotide Clients Analysis
12.4 Octreotide Sales Channel and Sales Model Analysis
12.4.1 Octreotide Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Octreotide Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Octreotide Distributors
13 Market Dynamics
13.1 Octreotide Industry Trends
13.2 Octreotide Market Drivers
13.3 Octreotide Market Challenges
13.4 Octreotide Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer